Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00279786 · ClinicalTrials.gov registry record
B2-Adrenergic Receptor Polymorphisms
A clinical trial of Status Asthmaticus, sponsored by Connecticut Children's Medical Center.
- Completed
- Registry status
- 126
- Enrollment target
- 1
- Study location
NCT00279786 is a study of Status Asthmaticus that has completed, run by Connecticut Children's Medical Center. The registered enrollment target is 126 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00279786, a study of Status Asthmaticus, has completed, sponsored by Connecticut Children's Medical Center.
- COMPLETED
- Registry status
- 126 participants
- Enrollment target
- 1
- Study location
Study Summary
Beta(2)-adrenergic receptor (BAR) agonists are the most important group of drugs used in the treatment of asthma. In children unresponsive to inhaled BAR agonist therapy, higher dose systemic BAR agonist therapy is frequently the next step in treatment. Despite the widespread use of intravenous BAR agonist therapy for pediatric status asthmaticus, there is controversy regarding the efficacy of this therapy. A number of studies have established that genetic variations of the BAR have important effects in modulating responses to BAR agonist therapy for asthma. In particular, changes in amino acid position 16 of the BAR gene are thought to be the most functionally important. Patients encoded for two glycine amino acids, rather than arginine, at this position appear to have more severe asthma and to respond differently to acute BAR agonist therapy. Our hypothesis is that genotypic differences may contribute to poor response to acute BAR agonist treatment. We propose to conduct a prospective observational study to determine the influence of a patient's BAR genotype on the response to acute BAR agonist therapy. Our specific hypothesis is that children with genetic polymorphisms of the gene encoding the BAR will have a decreased response to acute high-dose continuous BAR therapy (both inhaled and intravenous) compared to other children. Our primary outcome is ICU length of stay. Secondary outcomes are 1. to assess the rate of improvement in clinical asthma score based on genotype, and 2. to attempt to correlate asthma phenotype with genotype by comparing demographic data and hospital course.
Conditions Studied
Interventions
- PROCEDURE Blood draw
Study Locations (1)
Connecticut
- CT Children's Medical Center - Hartford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2005-12 |
| Est. Completion | 2009-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00279786
The ClinicalTrials.gov registry entry for NCT00279786 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 126 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Connecticut Children's Medical Center, which has 55 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Status Asthmaticus appearing as the primary indexed condition, and to 1 intervention - of which Blood draw is the first listed.
NCT00279786 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT00279786 about?
NCT00279786 is a clinical study titled "B2-Adrenergic Receptor Polymorphisms". Beta(2)-adrenergic receptor (BAR) agonists are the most important group of drugs used in the treatment of asthma. In children unresponsive to inhaled BAR agonist therapy, higher dose systemic BAR agonist therapy is frequently the next step in treatment. Despite the widespread use of intravenous BAR ...
What is the current status of trial NCT00279786?
This trial is currently completed. The enrollment target is 126 participants. The study started on 2005-12. Estimated completion is 2009-01.
What conditions does trial NCT00279786 study?
This clinical trial studies the following conditions: Status Asthmaticus.
What interventions are being tested in trial NCT00279786?
The interventions under investigation include: Blood draw (PROCEDURE).
Who is sponsoring clinical trial NCT00279786?
This trial is sponsored by Connecticut Children's Medical Center, which has 55 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00279786 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Status Asthmaticus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.